Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PLXP
2751
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $612K | ﹤0.01% |
5,275
+800
| +18% | +$78K |
2015 Q3
4 quarters
|
|
2752
Ardelyx
ARDX
$847M
| $608K | ﹤0.01% |
+47,000
| New | +$492K |
2016 Q3
0 quarters
|
|
|
AHGP
2753
DELISTED
Alliance Holdings GP
AHGP
| $607K | ﹤0.01% |
23,300
+4,385
| +23% | +$107K |
2013 Q4
11 quarters
|
|
2754
Kingstone Companies
KINS
$268M
| $606K | ﹤0.01% |
65,667
+20,167
| +44% | +$181K |
2014 Q4
7 quarters
|
|
|
SOHO
2755
DELISTED
Sotherly Hotels
SOHO
| $602K | ﹤0.01% |
113,978
+11,478
| +11% | +$66.5K |
2014 Q3
8 quarters
|
|
2756
NLI Holdings
NL
$339M
| $600K | ﹤0.01% |
152,600
+25,500
| +20% | +$90.2K |
2014 Q4
7 quarters
|
|
|
ENFC
2757
DELISTED
Entegra Financial Corp.
ENFC
| $599K | ﹤0.01% |
32,600
+15,100
| +86% | +$268K |
2015 Q4
3 quarters
|
|
2758
Taylor Devices
TAYD
$190M
| $598K | ﹤0.01% |
30,300
+2,900
| +11% | +$56K |
2015 Q3
4 quarters
|
|
2759
The Bancorp
TBBK
$1.97B
| $594K | ﹤0.01% |
92,600
-70,200
| -43% | -$406K |
2015 Q2
5 quarters
|
|
2760
Full House Resorts
FLL
$44.3M
| $593K | ﹤0.01% |
331,500
+41,200
| +14% | +$77.4K |
2013 Q4
11 quarters
|
|
|
GMLP
2761
DELISTED
Golar LNG Partners LP
GMLP
| $589K | ﹤0.01% |
+30,000
| New | +$568K |
2016 Q3
0 quarters
|
|
2762
Fate Therapeutics
FATE
$261M
| $587K | ﹤0.01% |
188,000
+7,300
| +4% | +$17.7K |
2015 Q1
6 quarters
|
|
|
AUTO
2763
DELISTED
AutoWeb, Inc. Common Stock
AUTO
| $587K | ﹤0.01% |
33,000
-18,300
| -36% | -$294K |
2013 Q2
13 quarters
|
|
2764
Agilent Technologies
A
$48.1B
| $584K | ﹤0.01% |
12,400
-406,600
| -97% | -$19M |
2015 Q4
3 quarters
|
|
|
ECYT
2765
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $584K | ﹤0.01% |
+189,000
| New | +$589K |
2016 Q3
0 quarters
|
|
2766
NanoViricides
NNVC
$33.2M
| $582K | ﹤0.01% |
17,215
+100
| +0.6% | +$3.31K |
2014 Q4
7 quarters
|
|
2767
USA Compression Partners
USAC
$3.76B
| $582K | ﹤0.01% |
31,000
-52,800
| -63% | -$841K |
2016 Q2
1 quarter
|
|
2768
TriMas Corp
TRS
$1.37B
| $579K | ﹤0.01% |
31,100
-53,900
| -63% | -$997K |
2016 Q1
2 quarters
|
|
|
UMH
2769
UMH Properties
UMH
$1.3B
| $573K | ﹤0.01% |
48,100
-406,700
| -89% | -$4.91M |
2014 Q3
8 quarters
|
|
|
FLOW
2770
DELISTED
SPX FLOW, Inc.
FLOW
| $569K | ﹤0.01% |
+18,400
| New | +$513K |
2016 Q3
0 quarters
|
|
|
CTO
2771
CTO Realty Growth
CTO
$768M
| $568K | ﹤0.01% |
40,900
+23,585
| +136% | +$318K |
2016 Q2
1 quarter
|
|
2772
ImmuCell
ICCC
$89M
| $567K | ﹤0.01% |
73,300
+9,100
| +14% | +$66.2K |
2013 Q2
13 quarters
|
|
|
CWBC
2773
Community West Bancshares
CWBC
$698M
| $565K | ﹤0.01% |
35,600
+3,200
| +10% | +$48.4K |
2016 Q2
1 quarter
|
|
|
RXDX
2774
DELISTED
Ignyta, Inc.
RXDX
| $565K | ﹤0.01% |
+89,900
| New | +$522K |
2016 Q3
0 quarters
|
|
|
EPE
2775
DELISTED
EP Energy Corporation
EPE
| $564K | ﹤0.01% |
128,728
+85,528
| +198% | +$357K |
2015 Q1
6 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.